EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology

Landon John-Patrick Thompson, Jessica Genovese, Zhenzi Hong, Meera Vir Singh, Vir Bahadur Singh iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094697 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Landon John-Patrick Thompson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY 12208, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite combined antiretroviral therapy (cART) limiting HIV replication to undetectable levels in the blood, people living with HIV continue to experience HIV-associated neurocognitive disorder (HAND). HAND is associated with neurocognitive impairment, including motor impairment, and memory loss. HIV has been detected in the brain within 8 days of estimated exposure and the mechanisms for this early entry are being actively studied. Once having entered into the central nervous system (CNS), HIV degrades the blood–brain barrier through the production of its gp120 and Tat proteins. These proteins are directly toxic to endothelial cells and neurons, and propagate inflammatory cytokines by the activation of immune cells and dysregulation of tight junction proteins. The BBB breakdown is associated with the progression of neurocognitive disease. One of the main hurdles for treatment for HAND is the latent pool of cells, which are insensitive to cART and prolong inflammation by harboring the provirus in long-lived cells that can reactivate, causing damage. Multiple strategies are being studied to combat the latent pool and HAND; however, clinically, these approaches have been insufficient and require further revisions. The goal of this paper is to aggregate the known mechanisms and challenges associated with HAND.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierHumansHIV InfectionsAIDS Dementia ComplexHIV-1Neurocognitive DisordersAnimals

Stichwörter der Autor:innen

HANDHIVlatencymicroglianeuroinflammationplatelet

Autor:innen und Institutionen

  • Department of Life Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY 12208, USA.
  • Department of Neurology, University of Rochester, Rochester, NY 14642, USA.

ORCID-Profile: Vir Bahadur Singh

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Thompson, L. J., Genovese, J., Hong, Z., Singh, M. V., & Singh, V. B. (2024). HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094697

Vancouver

Thompson LJ, Genovese J, Hong Z, Singh MV, Singh VB. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094697

BibTeX
@article{Thompson2024,
  author = {Thompson, Landon John-Patrick and Genovese, Jessica and Hong, Zhenzi and Singh, Meera Vir and Singh, Vir Bahadur},
  title = {HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094697}
}
Kostenlos starten →